CKPT
Price
$2.77
Change
-$0.23 (-7.67%)
Updated
Jan 22, 04:08 PM (EDT)
Capitalization
146.5M
CYTK
Price
$46.93
Change
+$1.11 (+2.42%)
Updated
Jan 22, 04:12 PM (EDT)
Capitalization
5.41B
29 days until earnings call
Ad is loading...

CKPT vs CYTK

Header iconCKPT vs CYTK Comparison
Open Charts CKPT vs CYTKBanner chart's image
Checkpoint Therapeutics
Price$2.77
Change-$0.23 (-7.67%)
Volume$500
Capitalization146.5M
Cytokinetics
Price$46.93
Change+$1.11 (+2.42%)
Volume$1.3K
Capitalization5.41B
CKPT vs CYTK Comparison Chart
Loading...
CKPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CKPT vs. CYTK commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CKPT is a Hold and CYTK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 22, 2025
Stock price -- (CKPT: $3.00 vs. CYTK: $45.82)
Brand notoriety: CKPT and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CKPT: 69% vs. CYTK: 105%
Market capitalization -- CKPT: $146.5M vs. CYTK: $5.41B
CKPT [@Biotechnology] is valued at $146.5M. CYTK’s [@Biotechnology] market capitalization is $5.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $341.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CKPT’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • CKPT’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than CKPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CKPT’s TA Score shows that 2 TA indicator(s) are bullish while CYTK’s TA Score has 2 bullish TA indicator(s).

  • CKPT’s TA Score: 2 bullish, 4 bearish.
  • CYTK’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both CKPT and CYTK are a bad buy in the short-term.

Price Growth

CKPT (@Biotechnology) experienced а -5.36% price change this week, while CYTK (@Biotechnology) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +2.45%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

CKPT is expected to report earnings on May 15, 2023.

CYTK is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.41B) has a higher market cap than CKPT($146M). CYTK YTD gains are higher at: -2.594 vs. CKPT (-6.250). CKPT has higher annual earnings (EBITDA): -37.51M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. CKPT (4.7M). CKPT has less debt than CYTK: CKPT (2.47M) vs CYTK (790M). CYTK has higher revenues than CKPT: CYTK (3.22M) vs CKPT (47K).
CKPTCYTKCKPT / CYTK
Capitalization146M5.41B3%
EBITDA-37.51M-481.94M8%
Gain YTD-6.250-2.594241%
P/E RatioN/AN/A-
Revenue47K3.22M1%
Total Cash4.7M1.01B0%
Total Debt2.47M790M0%
FUNDAMENTALS RATINGS
CKPT vs CYTK: Fundamental Ratings
CKPT
CYTK
OUTLOOK RATING
1..100
5975
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10051
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4482
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CKPT's Valuation (91) in the Pharmaceuticals Major industry is in the same range as CYTK (100) in the Biotechnology industry. This means that CKPT’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (51) in the Biotechnology industry is somewhat better than the same rating for CKPT (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew somewhat faster than CKPT’s over the last 12 months.

CYTK's SMR Rating (100) in the Biotechnology industry is in the same range as CKPT (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew similarly to CKPT’s over the last 12 months.

CKPT's Price Growth Rating (44) in the Pharmaceuticals Major industry is somewhat better than the same rating for CYTK (82) in the Biotechnology industry. This means that CKPT’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CKPT (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew significantly faster than CKPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CKPTCYTK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 15 days ago
90%
Bearish Trend 15 days ago
83%
Momentum
ODDS (%)
Bearish Trend 15 days ago
81%
Bearish Trend 15 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 15 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 15 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 15 days ago
75%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 15 days ago
77%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 15 days ago
83%
View a ticker or compare two or three
Ad is loading...
CKPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INDS36.380.89
+2.49%
Pacer Benchmark Industrial RE SCTR ETF
EWC41.230.68
+1.68%
iShares MSCI Canada ETF
AVGE74.960.90
+1.22%
Avantis All Equity Markets ETF
IIGD24.170.02
+0.10%
Invesco Investment Grade Defensive ETF
DMAT14.98N/A
N/A
Global X Disruptive Materials ETF

CKPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CKPT has been loosely correlated with CYCC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CKPT jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CKPT
1D Price
Change %
CKPT100%
-5.66%
CYCC - CKPT
52%
Loosely correlated
+1.15%
GPCR - CKPT
43%
Loosely correlated
+4.73%
CYTK - CKPT
42%
Loosely correlated
+0.17%
CARA - CKPT
40%
Loosely correlated
-1.08%
AXON - CKPT
37%
Loosely correlated
+1.97%
More

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+0.17%
TRDA - CYTK
44%
Loosely correlated
+2.92%
KRON - CYTK
43%
Loosely correlated
-0.04%
DARE - CYTK
42%
Loosely correlated
-0.30%
CKPT - CYTK
41%
Loosely correlated
-5.66%
ACLX - CYTK
40%
Loosely correlated
+0.14%
More